Posted in | News | Ferrous Alloys and Metals | Iron and Steel

Xstrata to Cease production at Vantech Vanadium Plant

Nov 11 2003

Related Stories

Xstrata will suspend production of vanadium from their Vantech vanadium plant, effective January 1, 2004, placing the plant into care and maintenance. This decision has been taken as the ore body being mined has reached the end of its natural life.

Continued production is possible if they decide to develop the Steelpoortdrift ore body. However, this has been deferred due to weakness in the vanadium price and the strength of the South African Rand.

The suspension of production will reduce annual production capacity of vanadium pentoxide (V2O5) by 13.5 million pounds per year.

For more information on vanadium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback